Your browser doesn't support javascript.
Retinal toxicity caused by hydroxychloroquine in patients with systemic lupus erythematosus: A case report.
Wang, Gang; Zhuo, Ning; Liao, Zheng; Qi, Wei; Tian, Feng; Wen, Zhenhua; Li, Jingyang.
  • Wang G; Department of Rheumatology and Immunology, Zhuzhou Hospital Affiliated to Xiangya Medical College, Central South University, Zhuzhou.
  • Zhuo N; Department of Nephrology, Xiangya Second Hospital, Central South University, Changsha.
  • Liao Z; Department of Rheumatology and Immunology, Zhuzhou Hospital Affiliated to Xiangya Medical College, Central South University, Zhuzhou.
  • Qi W; Department of Ophthalmology, Zhuzhou Hospital Affiliated to Xiangya Medical College, Central South University, Zhuzhou, Hunan, China.
  • Tian F; Department of Rheumatology and Immunology, Zhuzhou Hospital Affiliated to Xiangya Medical College, Central South University, Zhuzhou.
  • Wen Z; Department of Rheumatology and Immunology, Zhuzhou Hospital Affiliated to Xiangya Medical College, Central South University, Zhuzhou.
  • Li J; Department of Rheumatology and Immunology, Zhuzhou Hospital Affiliated to Xiangya Medical College, Central South University, Zhuzhou.
Medicine (Baltimore) ; 100(22): e25688, 2021 Jun 04.
Article in English | MEDLINE | ID: covidwho-1257893
ABSTRACT
RATIONALE Hydroxychloroquine has excellent anti-inflammatory and immunomodulatory effects as one of the antimalarial drugs. In particular, hydroxychloroquine was once widely used as a treatment for the new coronavirus pneumonia epidemic in 2020. Retinopathy caused by hydroxychloroquine is normally irreversible, but little attention has been paid to it. PATIENT CONCERNS A 38-year-old young Chinese woman was taking oral hydroxychloroquine 400 mg daily to control lupus disease activity for six years after the diagnosis of systemic lupus erythematosus (SLE). She did not have any history of eye disease and was admitted to the hospital with a sudden blurring of both eyes. DIAGNOSES The diagnosis of retinal macular degeneration caused by hydroxychloroquine was made after excluding other interfering diseases based on the patient's long-term use of hydroxychloroquine and the results of the eye examination.

INTERVENTIONS:

The patient was discontinued from hydroxychloroquine. To control the recurrence of SLE, she was given intravenous methylprednisolone, oral tacrolimus and mycophenolate. Meanwhile, she was asked to take extra care of her eyes and to come to the hospital every three months to have her vision checked.

OUTCOMES:

The patient's blurred vision improved one week later. Three months later, her vision examination showed no further decline (0.4 in the right eye and 0.6 in the left eye). Meanwhile, the SLE disease activity index (SLEDAI) decreased from six points to five points currently. LESSONS Retinopathy caused by hydroxychloroquine is irreversible and there is no particularly effective treatment. Discontinuation of hydroxychloroquine, better daily eye protection, and regular vision checks are the keys to preventing retinopathy. Although hydroxychloroquine causing retinal toxicity was mentioned several years ago, the rate and severity of retinal toxicity require further research. How to get more patients to take care of their eyes requires continuous and increased education by doctors.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Retinal Diseases / Hydroxychloroquine / Lupus Erythematosus, Systemic / Anti-Inflammatory Agents Type of study: Case report / Observational study / Prognostic study Limits: Adult / Female / Humans Language: English Journal: Medicine (Baltimore) Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Retinal Diseases / Hydroxychloroquine / Lupus Erythematosus, Systemic / Anti-Inflammatory Agents Type of study: Case report / Observational study / Prognostic study Limits: Adult / Female / Humans Language: English Journal: Medicine (Baltimore) Year: 2021 Document Type: Article